GuiZhou SanLi Pharmaceutical Co.,Ltd (603439.SS) SHH

12.36

+0.07(+0.57%)

Updated at November 11 02:04PM

Currency In CNY

Valuation

Market Cap5.32B
Enterprise Value5.4B
P/E Ratio21.55
PEG Ratio-2.71
Price/Sales Ratio2.58
Price/Book Ratio3.5
Enterprise/Revenue2.81
Enterprise/EBITDA18.6

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.12
Operating Margin0.14

Management Effectiveness

Return On Assets0.08
Return On Equity0.16

Income Statement

Revenue2.14B
Revenue/Share4.58
Gross Profit1.49B
EBITDA415.41M
Net Income274.03M
Diluted EPS0.67

Balance Sheet

Total Cash303.05M
Total Cash/Share0.72
Total Debt722.49M
Total Debt/Equity0.49
Current Ratio1.42
Book Value Per Share3.69

Price History

52-Week Change-14.91
52-Week High14.96
52-Week Low11.45
Moving Average 50 Days12.63
Moving Average 200 Days12.6

Statistics

Average Volume6.35M
Shares Outstanding402.17M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.34
Trailing Annual Dividend Yield2.76
Payout Ratio0.67
Last Split FactorN/A
Last Split DateN/A